Acute colonic pseudo-obstruction with transient failure of oral desmopressin in adipsic arginine vasopressin deficiency.
In patients with adipsic AVP deficiency, acute colonic pseudo-obstruction may impair the absorption of oral desmopressin, necessitating careful management of administration timing.
Where it sits
this study against the rest of the vasopressin corpusSummary and findings
This case report discusses a middle-aged male with adipsic arginine vasopressin deficiency who experienced severe hyponatremia and acute colonic pseudo-obstruction. Management included bowel regimen and endoscopic decompression, with issues noted in the absorption of oral desmopressin. After gastrointestinal recovery, oral desmopressin was effective in producing sustained antidiuresis.
Abstract
We report the case of a middle-aged male with panhypopituitarism and adipsic arginine vasopressin deficiency (AVP-D) who presented with severe hyponatremia. During the correction of hyponatremia, he developed acute colonic pseudo-obstruction (ACPO or Ogilvie syndrome). Management included a bowel regimen, rectal tube placement, and endoscopic decompression. During hospitalization, repeated transitions from intravenous to oral desmopressin were consistently followed by brisk hypotonic polyuria and hypernatremia, raising concern for impaired enteral desmopressin absorption. After gastrointestinal recovery and separation of oral desmopressin and polyethylene glycol (PEG) by more than 4 hours, oral desmopressin again produced sustained antidiuresis. This case suggests that ACPO may transiently impair oral desmopressin absorption and that concurrent PEG administration may further reduce its efficacy.
Background
This paper addresses the clinical implications of adipsic arginine vasopressin deficiency and its management in the context of acute colonic pseudo-obstruction. Prior knowledge indicates that vasopressin plays a crucial role in fluid regulation, and disturbances can lead to significant clinical challenges. Understanding how gastrointestinal conditions affect medication absorption is essential for optimizing treatment strategies.
Methods
This is a case report detailing the clinical course of a single middle-aged male patient with panhypopituitarism and adipsic arginine vasopressin deficiency. The patient experienced severe hyponatremia and was treated with intravenous and oral desmopressin, alongside bowel management strategies. The focus was on the absorption of oral desmopressin during episodes of acute colonic pseudo-obstruction.
Results
The patient developed acute colonic pseudo-obstruction during treatment for severe hyponatremia. Oral desmopressin was ineffective when administered concurrently with polyethylene glycol but was effective after a separation of more than 4 hours post-PEG administration.
Interpretation
The findings suggest that acute colonic pseudo-obstruction may transiently impair the absorption of oral desmopressin, which is consistent with existing literature on gastrointestinal absorption issues. However, the clinical significance of the observed effects is uncertain due to the lack of statistical analysis and the small sample size. The case highlights the need for careful management of medication timing in patients with gastrointestinal complications.
Key findings
- Developed acute colonic pseudo-obstruction during treatment for severe hyponatremia.
- Oral desmopressin produced sustained antidiuresis after separation from polyethylene glycol by more than 4 hours.
Limitations
- Case report with a single patient, limiting generalizability.
- No control group to compare outcomes.
- Lack of statistical analysis for observed effects.